AKYA Tiesioginiai signalai | Didinkite pelną su Getagraph.com

PARDAVIMAS 108293 min ago

@ $5.47

Išleistas: 14 vas. 2024 @ 21:51

Grąža: -29.43%

Ankstesnis signalas: vas. 14 - 19:36

Ankstesnis signalas: Pirkimas

Grąža: 1.86 %

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 23:00):

Stats
Šios dienos apimtis	62 832.00
Vidutinė apimtis	180 475
Rinkos kapitalizacija	190.61M
EPS	$0 ( 2024-03-04 )
Kita pelno data	( $-0.300 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.70
ATR14	$0.00800 (0.21%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Ek John Frederick	Sell	14 272	Common Stock
2024-03-23	Pla Frederic	Sell	2 006	Common Stock
2024-03-23	Ramachandran Niro Ph.d	Sell	2 006	Common Stock
2024-03-23	Mckelligon Brian	Sell	7 135	Common Stock
2024-03-20	Mckelligon Brian	Sell	7 500	Employee Stock Option (Right to Buy)

INSIDER POWER
67.45
Last 99 transactions
Buy: 5 199 597 \| Sell: 937 556

Tūris Koreliacija

Ilgas: -0.03 (neutral)

Trumpas: -0.06 (neutral)

Signal:(59.052) Neutral

Akoya Biosciences, Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
MTLS	0.969
FATE	0.966
IHRT	0.965
CUE	0.965
EAR	0.962
CBAN	0.961
SSBK	0.96
PNFP	0.959
FGBI	0.959
FNCB	0.958

10 Labiausiai neigiamai susiję koreliacijos
OHAA	-0.95
BRIVU	-0.942
NVCN	-0.942
PRDO	-0.94
PPYAU	-0.939
MSDA	-0.939
HDSN	-0.932
SENEA	-0.93
TIOA	-0.928
XFIN	-0.928

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Akoya Biosciences, Inc. Koreliacija - Valiuta/Žaliavos

-0.33
( neutral )

-0.42
( neutral )

0.00
( neutral )

-0.24
( neutral )

-0.25
( neutral )

Akoya Biosciences, Inc. Finansinės ataskaitos

Annual	2023
Pajamos:	$96.63M
Bruto pelnas:	$48.24M (49.92 %)
EPS:	$-1.430

FY	2023
Pajamos:	$96.63M
Bruto pelnas:	$48.24M (49.92 %)
EPS:	$-1.430

FY	2022
Pajamos:	$74.86M
Bruto pelnas:	$43.39M (57.96 %)
EPS:	$-1.870

FY	2021
Pajamos:	$54.92M
Bruto pelnas:	$13.52M (24.62 %)
EPS:	$-1.485

Financial Reports:

No articles found.

Akoya Biosciences, Inc.

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.